Eagle Pharmaceuticals, Inc. Retained Earnings
Eagle Pharmaceuticals, Inc. had Retained Earnings of $122.42 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-08-09
- 2023-06-30: Retained Earnings (Accumulated Deficit) $122.42M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) $117.25M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) $111.50M.
- 2022-09-30: Retained Earnings (Accumulated Deficit) $103.34M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2023-06-30 | $122.42M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $117.25M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $111.50M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $103.34M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $110.47M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $119.92M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $75.86M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $82.06M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $87.68M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $84.07M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $84.49M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $76.43M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $69.37M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $69.63M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $72.50M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $71.50M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $73.89M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $67.16M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $58.19M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $45.60M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $31.56M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $28.90M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $26.28M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $17.20M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.77M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$2.73M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$25.66M 10-K · filed 2018-02-26 | |
| 2016-09-30 | -$82.96M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$94.91M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$108.01M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$107.11M 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$108.33M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$98.16M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | -$89.99M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$109.68M 10-K · filed 2016-02-29 | |
| 2014-09-30 | -$104.18M 10-K · filed 2016-02-29 | |
| 2014-06-30 | -$95.07M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$92.14M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | -$102.14M 10-K · filed 2014-12-22 | -$102.14M 10-Q · filed 2014-05-15 |